You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 25, 2024

Patent: 5,215,895


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,215,895
Title: DNA encoding a mammalian cytokine, interleukin-11
Abstract:A novel mammalian cytokine, IL-11, and processes for producing it are disclosed. IL-11 may be used in pharmaceutical preparations for stimulating and/or enhancing cells involved in the immune response and cells involved in the proper functioning of the hematopoietic system.
Inventor(s): Bennett; Frances K. (Melrose, MA), Paul; Stephen R. (Boston, MA), Yang; Yu-Chung (Indianapolis, IN)
Assignee: Genetics Institute, Inc. (Cambridge, MA)
Application Number:07/526,474
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Analyzing the Patent Landscape: A Comprehensive Look at United States Patent 5,215,895

Introduction

Patents are a cornerstone of innovation, providing inventors and companies with the exclusive rights to their inventions. Understanding the patent landscape is crucial for navigating the complex world of intellectual property. This article will delve into the specifics of United States Patent 5,215,895, examining its claims, the broader patent landscape, and the tools and regulations that shape this environment.

Understanding the Patent

To begin with, let's understand what United States Patent 5,215,895 entails. While the specific details of this patent are not provided here, a general approach to analyzing any patent involves several key steps:

Patent Claims

The claims section of a patent is the most critical part, as it defines the scope of the invention. These claims must be clear, concise, and definite to ensure that the patent holder's rights are well-defined and enforceable. For any patent, including 5,215,895, the claims should be scrutinized to understand what is being protected and what potential limitations or vulnerabilities exist[1].

Background and Description

The background and description sections provide context and detail about the invention. These sections help in understanding the problem the invention solves, the prior art, and how the invention improves upon existing solutions. This information is vital for assessing the novelty and nonobviousness of the invention, two fundamental requirements for patentability[2].

The Broader Patent Landscape

Global Patent System

The global patent system is increasingly interconnected. Tools like the Global Dossier and the Common Citation Document (CCD) facilitate access to patent information across different intellectual property offices. The Global Dossier, for instance, allows users to view the file histories of related applications from participating IP Offices, including the IP5 Offices (USPTO, EPO, JPO, KIPO, and CNIPA)[1].

International Patent Databases

Searching international patent databases is essential to ensure that an invention is novel and nonobvious on a global scale. Databases such as the European Patent Office's esp@cenet, the Japan Patent Office's database, and the World Intellectual Property Organization's PATENTSCOPE provide comprehensive access to published patent applications and granted patents worldwide[1].

Regulatory Developments and Their Impact

The Leahy-Smith America Invents Act (AIA)

The AIA, enacted in 2011, significantly altered the U.S. patent landscape. It introduced the Patent Trial and Appeal Board (PTAB) and new procedures like Inter Partes Review (IPR) and Post-Grant Review (PGR), which allow for administrative challenges to the validity of patents. These changes aim to improve patent quality and reduce unwarranted litigation costs, but they have also been criticized for creating uncertainty and making it easier to challenge patents[2].

Patent Eligibility and the Alice/Mayo Test

The Supreme Court's Alice/Mayo framework has been instrumental in determining patentable subject matter. This two-step test assesses whether patent claims are directed to ineligible subject matter (such as laws of nature, natural phenomena, or abstract ideas) and whether they contain an "inventive concept" that transforms the nature of the claim into a patent-eligible application. This framework has been a focal point in many patent disputes and has influenced how patents are drafted and challenged[2].

Tools for Patent Searching and Analysis

Patent Public Search

The USPTO's Patent Public Search tool is a powerful resource for conducting preliminary patent searches. It offers modern interfaces and enhanced access to prior art, improving the overall patent searching process. This tool is indispensable for identifying existing patents and published patent applications that could impact the validity of a new patent[1].

Patent and Trademark Resource Centers (PTRCs)

PTRCs provide local resources and training in patent search techniques. These centers are valuable for inventors and companies looking to conduct thorough searches and understand the patent landscape in their specific field[1].

Patent Examination Data System (PEDS)

The PEDS allows public users to search, view, and download bibliographic data for all publicly available patent applications. This system is particularly useful for analyzing trends and patterns in patent filings and can help in strategizing patent applications and challenges[1].

Litigation and Enforcement

Patent Litigation Trends

Patent litigation remains a significant concern, especially with the rise of technology-related patents and the involvement of non-practicing entities (NPEs) or "patent trolls." In 2023, US patent litigations totaled over 4,660, with a substantial portion attributed to NPEs. This landscape underscores the importance of robust patent protection and enforcement strategies[3].

The Unified Patent Court (UPC) in Europe

The establishment of the UPC in Europe has centralized patent litigation across 17 EU member states. While this simplifies the process for patent holders, it also raises concerns about the potential for NPEs to exploit the system. The UPC has already handled over 155 litigation cases and issued numerous injunctions, highlighting its impact on the European patent landscape[3].

Insurance and Risk Management

IP Insurance Coverage

Given the increasing volatility in the patent arena, IP-related insurance coverage has become more critical. This coverage focuses on areas such as IP infringement liability, IP rights protection, IP rights enforcement, and contractual disputes. As regulatory developments continue to shape the patent landscape, companies must assess and potentially expand their IP-related cover to mitigate risks[3].

The Role of AI in Patent Applications

USPTO Guidance on AI Tools

The USPTO has issued guidance on the use of AI tools in patent applications, emphasizing the need to disclose any material information related to AI contributions. This includes ensuring that AI-assisted contributions do not introduce inaccurate statements or omit material information. Practitioners must verify the accuracy of all documents prepared with AI assistance to maintain the integrity of the patent application process[5].

Key Takeaways

  • Patent Claims: The claims section is crucial for defining the scope of the invention and must be clear, concise, and definite.
  • Global Patent System: Tools like the Global Dossier and CCD facilitate access to patent information globally.
  • Regulatory Developments: The AIA and the Alice/Mayo framework significantly impact patent validity and challenges.
  • Patent Searching Tools: Resources like the Patent Public Search and PEDS are essential for thorough patent searches.
  • Litigation Trends: Patent litigation, especially involving NPEs, remains a significant concern.
  • UPC in Europe: The UPC has centralized patent litigation in Europe, with both benefits and challenges.
  • IP Insurance: Given the increasing volatility, IP-related insurance coverage is becoming more important.
  • AI in Patent Applications: Disclosure and verification of AI contributions are critical to maintain the integrity of patent applications.

FAQs

Q: What is the significance of the claims section in a patent? A: The claims section defines the scope of the invention and must be clear, concise, and definite to ensure enforceable rights.

Q: How does the Global Dossier facilitate patent searches? A: The Global Dossier provides access to the file histories of related applications from participating IP Offices, including the IP5 Offices.

Q: What is the impact of the Leahy-Smith America Invents Act (AIA) on patent challenges? A: The AIA introduced PTAB and new procedures like IPR and PGR, which allow for administrative challenges to patent validity, aiming to improve patent quality and reduce litigation costs.

Q: How does the Alice/Mayo framework influence patent eligibility? A: The Alice/Mayo framework is a two-step test that determines whether patent claims are directed to ineligible subject matter and whether they contain an "inventive concept" that transforms the claim into a patent-eligible application.

Q: What is the role of the Unified Patent Court (UPC) in Europe? A: The UPC centralizes patent litigation across 17 EU member states, simplifying the process for patent holders but also raising concerns about NPE exploitation.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. Congressional Research Service - The Patent Trial and Appeal Board and Inter Partes Review: https://crsreports.congress.gov/product/pdf/R/R48016
  3. The Insurer - Shifting Patent Landscape Amplifies Need For IP Cover: https://insurance.archgroup.com/shifting-patent-landscape-amplifies-need-for-ip-cover/
  4. U.S. Department of Commerce - U.S. Patent and Trademark Office: https://www.commerce.gov/bureaus-and-offices/uspto
  5. Buchanan Ingersoll & Rooney PC - U.S. Patent Office Issues Additional Guidance on Use of AI Tools: https://www.bipc.com/united-states-patent-office-issues-guidance-on-use-of-ai-tools

More… ↓

⤷  Subscribe

Details for Patent 5,215,895

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Wyeth Pharmaceuticals Inc. NEUMEGA oprelvekin For Injection 103694 November 25, 1997 5,215,895 2010-06-01
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

International Patent Family for US Patent 5,215,895

Country Patent Number Estimated Expiration
World Intellectual Property Organization (WIPO) 9107495 ⤷  Subscribe
United States of America 6066317 ⤷  Subscribe
United States of America 5854028 ⤷  Subscribe
United States of America 5700664 ⤷  Subscribe
United States of America 5371193 ⤷  Subscribe
Mexico 9203439 ⤷  Subscribe
South Korea 970005050 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.